Supplementary Figure S1 from the Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab Plus Chemotherapy in Triple-Negative Breast Cancer

Supplementary Figure 1. Quality control of NeoTRIP RNA-Seq data. Boxplots showing the distribution of read depth of targeted coding regions by arm and response status. Dots represent the read depth of single samples. The horizontal grey dashed line represents the cut-off of 40 million paired-end reads.